Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Aug 15 2025

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 15, 2025, titled "Alembic Pharmaceuticals Limited announces USFDA Final Approval for Tretinoin Cream USP, 0.025%.".

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases